Filtros de búsqueda

Lista de obras de Robert M. Grant

A Mobile Health Strategy to Support Adherence to Antiretroviral Preexposure Prophylaxis

artículo científico publicado en 2018

A decrease in drug resistance levels of the HIV epidemic can be bad news

artículo científico publicado en 2005

A tale of two futures: HIV and antiretroviral therapy in San Francisco.

artículo científico publicado en 2000

AIDS. Promote HIV chemoprophylaxis research, don't prevent it.

artículo científico publicado en 2005

Absence of HBV and HCV, HTLV-I and -II, and human herpes virus-8 activation after allogeneic RBC transfusion in patients with advanced HIV-1 infection

artículo científico publicado en 2003

Acceptability of drug detection monitoring among participants in an open-label pre-exposure prophylaxis study

artículo científico publicado en 2015

Accuracy of the TRUGENE HIV-1 genotyping kit.

artículo científico publicado en 2003

Activation of virus replication after vaccination of HIV-1-infected individuals.

artículo científico publicado en 1995

Activity of a ritonavir plus saquinavir-containing regimen in patients with virologic evidence of indinavir or ritonavir failure ⬇️

artículo científico publicado el 9 de julio de 1998

Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome.

artículo científico publicado en 1989

Antiretroviral agents used by HIV-uninfected persons for prevention: pre- and postexposure prophylaxis

artículo científico publicado en 2010

Antiretroviral pre-exposure prophylaxis implementation in the United States: a work in progress

artículo científico publicado en 2015

Antiretroviral therapy for hepatitis B virus-HIV-coinfected patients: promises and pitfalls

artículo científico publicado en 2006

Association of age, baseline kidney function, and medication exposure with declines in creatinine clearance on pre-exposure prophylaxis: an observational cohort study

artículo científico publicado en 2016

Baseline Characteristics Explain Differences in Effectiveness of Randomization to Daily Oral TDF/FTC PrEP Between Transgender Women and Cisgender Men Who Have Sex With Men in the iPrEx Trial

scientific article published on 01 July 2019

Bone mineral density in HIV-negative men participating in a tenofovir pre-exposure prophylaxis randomized clinical trial in San Francisco

artículo científico publicado en 2011

Brief Report: HIV-1 gp120 T-Cell Responses Correspond to Infection Outcomes in the Global iPrEx Chemoprophylaxis Trial

artículo científico publicado en 2015

Brief Report: Recent Infection, Sexually Transmitted Infections, and Transmission Clusters Frequently Observed Among Persons Newly Diagnosed With HIV in San Francisco

artículo científico publicado en 2015

CD4+ T cell kinetics and activation in human immunodeficiency virus-infected patients who remain viremic despite long-term treatment with protease inhibitor-based therapy

artículo científico publicado en 2002

Cellular immune correlates analysis of an HIV-1 preexposure prophylaxis trial.

artículo científico publicado en 2015

Cerebrospinal fluid response to structured treatment interruption after virological failure.

artículo científico publicado en 2001

Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis

artículo científico publicado en 2014

Changes in seroadaptive practices from before to after diagnosis of recent HIV infection among men who have sex with men

artículo científico publicado en 2013

Characterization of HIV Seroconverters in a TDF/FTC PrEP Study: HPTN 067/ADAPT.

artículo científico publicado en 2017

Chemoprophylaxis of HIV Infection: Moving Forward with Caution

article

Daily and Nondaily Oral Preexposure Prophylaxis in Men and Transgender Women Who Have Sex With Men: The Human Immunodeficiency Virus Prevention Trials Network 067/ADAPT Study

artículo científico publicado en 2018

Daily and non-daily pre-exposure prophylaxis in African women (HPTN 067/ADAPT Cape Town Trial): a randomised, open-label, phase 2 trial

artículo científico publicado en 2017

Daily oral emtricitabine/tenofovir preexposure prophylaxis and herpes simplex virus type 2 among men who have sex with men

artículo científico publicado en 2014

Decline in HIV infectivity following the introduction of highly active antiretroviral therapy

artículo científico publicado en 2004

Dehydroepiandrosterone (DHEA) effects on HIV replication and host immunity: a randomized placebo-controlled study

artículo científico publicado en 2007

Depression and Oral FTC/TDF Pre-exposure Prophylaxis (PrEP) Among Men and Transgender Women Who Have Sex With Men (MSM/TGW).

artículo científico publicado en 2015

Detection of acute HIV infections

artículo científico publicado en 2005

Differences in Cumulative Exposure and Adherence to Tenofovir in the VOICE, iPrEx OLE, and PrEP Demo Studies as Determined via Hair Concentrations

artículo científico publicado en 2017

Differential persistence of transmitted HIV-1 drug resistance mutation classes

artículo científico publicado en 2011

Distinct patterns of cytokine regulation of APOBEC3G expression and activity in primary lymphocytes, macrophages, and dendritic cells

artículo científico publicado en 2006

Drug resistance and plasma viral RNA level after ineffective use of oral pre-exposure prophylaxis in women

artículo científico publicado en 2015

Dual pressure from antiretroviral therapy and cell-mediated immune response on the human immunodeficiency virus type 1 protease gene

artículo científico publicado en 2003

Duration and predictors of CD4 T-cell gains in patients who continue combination therapy despite detectable plasma viremia

artículo científico publicado en 2002

Editorial Commentary: Keeping Our Eyes on the Prize: No New HIV Infections With Increased Use of HIV Pre-exposure Prophylaxis

artículo científico publicado en 2015

Effectiveness and safety of oral HIV preexposure prophylaxis for all populations

artículo científico publicado en 2016

Effects of Emtricitabine/Tenofovir on Bone Mineral Density in HIV-Negative Persons in a Randomized, Double-Blind, Placebo-Controlled Trial

artículo científico publicado en 2015

Elevations in Serum Creatinine With Tenofovir-Based HIV Pre-Exposure Prophylaxis: A Meta-Analysis of Randomized Placebo-Controlled Trials

artículo científico publicado en 2015

Emergence of drug-resistant HIV-1 variants in patients undergoing structured treatment interruptions

artículo científico publicado en 2002

Emtricitabine-Triphosphate in Dried Blood Spots as a Marker of Recent Dosing

artículo científico publicado en 2016

Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men.

artículo científico publicado en 2012

Ending sexual HIV transmission: lessons learned from perinatal HIV.

artículo científico publicado en 2015

Evolution of phenotypic drug susceptibility and viral replication capacity during long-term virologic failure of protease inhibitor therapy in human immunodeficiency virus-infected adults

artículo científico publicado en 2002

Evolution of viral quasispecies in interferon-treated patients with chronic hepatitis C virus infection.

artículo científico publicado en 1999

Expanding the Menu of HIV Prevention Options: A Qualitative Study of Experiences with Long-Acting Injectable Cabotegravir as PrEP in the Context of a Phase II Trial in the United States

artículo científico publicado en 2017

Experiences with HPTN 067/ADAPT Study-Provided Open-Label PrEP Among Women in Cape Town: Facilitators and Barriers Within a Mutuality Framework

artículo científico publicado en 2016

Facilitators and barriers to medication adherence in an HIV prevention study among men who have sex with men in the iPrEx study in Chiang Mai, Thailand

artículo científico publicado en 2012

Frequent international travel by men who have sex with men recently diagnosed with HIV-1: potential for transmission of primary HIV-1 drug resistance.

artículo científico publicado en 2008

Frequent methamphetamine use is associated with primary non-nucleoside reverse transcriptase inhibitor resistance

artículo científico publicado en 2007

Gay and bisexual men engage in fewer risky sexual behaviors while traveling internationally: a cross-sectional study in San Francisco

artículo científico publicado en 2014

Genotypic resistance and immunologic outcomes among HIV-1-infected women with viral failure

artículo científico publicado en 2006

Greater CD4 T-cell gains after one year of antiretroviral therapy are associated with lower HIV-1 pol replication capacity

HIV RNA level in early infection is predicted by viral load in the transmission source

artículo científico publicado en 2010

HIV Serodisclosure and Sexual Behavior During International Travel

artículo científico publicado en 2016

HIV moments and pre-exposure prophylaxis.

artículo científico publicado en 2016

HIV pre-exposure prophylaxis in men who have sex with men and transgender women: a secondary analysis of a phase 3 randomised controlled efficacy trial

artículo científico publicado en 2014

HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial

artículo científico publicado en 2015

HIV prevention in clinical care settings: 2014 recommendations of the International Antiviral Society-USA Panel

artículo científico publicado en 2014

HIV sero disclosure among men who have sex with men and transgender women on HIV pre-exposure prophylaxis.

artículo científico publicado en 2017

HIV-1 Drug Resistance in Pre-exposure Prophylaxis Trials

article

HIV-1 drug resistance in the iPrEx preexposure prophylaxis trial

artículo científico publicado en 2014

HIV-1 superinfection and viral diversity

artículo científico publicado en 2004

HIV-1-Specific CD4+ T Cell Responses in Chronically HIV-1 Infected Blippers on Antiretroviral Therapy in Relation to Viral Replication Following Treatment Interruption

article

HIV-Producing T Cells in Cerebrospinal Fluid

article

HIV-related neuropathology, 1985 to 1999: rising prevalence of HIV encephalopathy in the era of highly active antiretroviral therapy

artículo científico publicado en 2002

Helping our patients take HIV pre-exposure prophylaxis (PrEP): a systematic review of adherence interventions.

artículo científico publicado en 2014

High levels of adherence do not prevent accumulation of HIV drug resistance mutations

artículo científico publicado en 2003

High prevalence of thymic tissue in adults with human immunodeficiency virus-1 infection.

artículo científico publicado en 1998

High-risk sexual behavior in adults with genotypically proven antiretroviral-resistant HIV infection

artículo científico publicado en 2005

Higher CD4+ T cell counts associated with low viral pol replication capacity among treatment-naive adults in early HIV-1 infection

artículo científico publicado en 2004

Human immunodeficiency virus type 1 Vpr induces DNA replication stress in vitro and in vivo.

artículo científico publicado en 2006

Human immunodeficiency virus type 1 superinfection was not detected following 215 years of injection drug user exposure

artículo científico publicado en 2004

Immunity to HIV-1 is influenced by continued natural exposure to exogenous virus.

artículo científico publicado en 2008

Impaired replication of protease inhibitor-resistant HIV-1 in human thymus.

artículo científico publicado en 2001

Increased human T-lymphotropic virus type II proviral load following highly active retroviral therapy in HIV-coinfected patients

artículo científico publicado en 2003

Increased thymic mass and circulating naive CD4 T cells in HIV-1-infected adults treated with growth hormone

artículo científico publicado en 2002

Increases in sexually transmitted infections and sexual risk behaviour without a concurrent increase in HIV incidence among men who have sex with men in San Francisco: a suggestion of HIV serosorting?

artículo científico publicado en 2006

Integrating Antiretroviral Strategies for Human Immunodeficiency Virus Prevention: Post- and Pre-Exposure Prophylaxis and Early Treatment

artículo científico publicado en 2015

International Sexual Partnerships May Be Shaped by Sexual Histories and Socioeconomic Status

artículo científico publicado en 2017

Interruption of treatment with individual therapeutic drug classes in adults with multidrug-resistant HIV-1 infection

artículo científico publicado en 2005

Is pericoital or peri-insemination preexposure prophylaxis effective human immunodeficiency prevention for vaginal exposures?

artículo científico publicado en 2017

Lack of persistent drug-resistant mutations evaluated within and between treatment interruptions in chronically HIV-1-infected patients

artículo científico publicado en 2003

Medication adherence, condom use and sexually transmitted infections in Australian preexposure prophylaxis users

artículo científico

No evidence of sexual risk compensation in the iPrEx trial of daily oral HIV preexposure prophylaxis

artículo científico publicado en 2013

Not all is dead in HIV-1 graveyard ⬇️

artículo científico publicado el 31 de enero de 1998

Participant experiences and facilitators and barriers to pill use among men who have sex with men in the iPrEx pre-exposure prophylaxis trial in San Francisco

artículo científico publicado en 2013

Patterns and correlates of PrEP drug detection among MSM and transgender women in the Global iPrEx Study

artículo científico publicado en 2014

Performance characteristics of the TRUGENE HIV-1 Genotyping Kit and the Opengene DNA Sequencing System

artículo científico publicado en 2003

Performance of the BioPlex 2200 HIV Ag-Ab assay for identifying acute HIV infection

artículo científico publicado en 2018

Persistence of drug-resistant HIV-1 after a structured treatment interruption and its impact on treatment response

artículo científico publicado en 2003

Persistence of primary drug resistance among recently HIV-1 infected adults

artículo científico publicado en 2004

Persistent HIV Type 1 Seronegative Status Is Associated With Lower CD8+ T-Cell Activation

artículo científico publicado en 2015

Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infection

artículo científico publicado en 2010

Pharmacology supports on-demand PrEP.

artículo científico publicado en 2016

Postexposure prophylaxis for human immunodeficiency virus infection after sexual or injection drug use exposure: identification and characterization of the source of exposure.

artículo científico publicado en 2001

Potentially exposed but uninfected individuals produce cytotoxic and polyfunctional human immunodeficiency virus type 1-specific CD8(+) T-cell responses which can be defined to the epitope level

artículo científico publicado en 2008

PrEP adherence among trans women in Brazil-access needed for this key population - Authors' reply

artículo científico publicado en 2016

Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men ⬇️

artículo científico publicado el 23 de noviembre de 2010

Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health Services

artículo científico publicado en 2015

Preexposure prophylaxis for HIV: unproven promise and potential pitfalls

artículo científico publicado en 2006

Progress toward a human CD4/CCR5 transgenic rat model for de novo infection by human immunodeficiency virus type 1.

artículo científico publicado en 2002

Randomized trial of clinical safety of daily oral tenofovir disoproxil fumarate among HIV-uninfected men who have sex with men in the United States.

artículo científico publicado en 2013

Randomized, controlled trial of therapy interruption in chronic HIV-1 infection

artículo científico publicado en 2004

Real-time quantitation of HIV-1 p24 and SIV p27 using fluorescence-linked antigen quantification assays

article

Recovery of Bone Mineral Density Following Discontinuation of Tenofovir-Based HIV Pre-Exposure Prophylaxis

artículo científico publicado en 2017

Regulatory considerations for antiretroviral prophylaxis to prevent HIV acquisition.

artículo científico publicado en 2014

Reply to Boyd et al.

artículo científico publicado en 2014

Research in situ

artículo científico publicado en 2007

Resistance Testing in Drug-Naive HIV-Infected Patients: Is it Time?

article

Response to: A double-edged sword: does highly active antiretroviral therapy contribute to syphilis incidence by impairing immunity to Treponema pallidum?

artículo científico publicado en 2017

Risk, safety and sex among male PrEP users: time for a new understanding.

artículo científico publicado en 2017

Roles of rpoD, spoIIF, spoIIJ, spoIIN, and sin in regulation of Bacillus subtilis stage II sporulation-specific transcription

artículo científico publicado en 1992

Routine surveillance for the detection of acute and recent HIV infections and transmission of antiretroviral resistance

artículo científico publicado en 2006

Safety and tolerability of long-acting cabotegravir injections in HIV-uninfected men (ECLAIR): a multicentre, double-blind, randomised, placebo-controlled, phase 2a trial

artículo científico

Selective loss of innate CD4(+) V alpha 24 natural killer T cells in human immunodeficiency virus infection

artículo científico publicado en 2002

Self-reported Recent PrEP Dosing and Drug Detection in an Open Label PrEP Study

artículo científico publicado en 2016

Sentinel surveillance of HIV-1 transmitted drug resistance, acute infection and recent infection

artículo científico publicado en 2011

Seroconversion following nonoccupational postexposure prophylaxis against HIV.

artículo científico publicado en 2005

Sex, PrEP, and Stigma: Experiences with HIV Pre-exposure Prophylaxis Among New York City MSM Participating in the HPTN 067/ADAPT Study.

artículo científico publicado en 2017

Sexual practices and risk of infection by the human immunodeficiency virus. The San Francisco Men's Health Study

artículo científico publicado en 1987

Sexual risk behaviours and HIV-1 prevalence among urban men who have sex with men in Cape Town, South Africa

artículo científico publicado en 2010

Sexual seroadaptation: lessons for prevention and sex research from a cohort of HIV-positive men who have sex with men

artículo científico publicado en 2010

Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors.

artículo científico publicado en 1998

Streamlining HIV testing for HIV preexposure prophylaxis

artículo científico publicado en 2014

Strong Correlation Between Concentrations of Tenofovir (TFV) Emtricitabine (FTC) in Hair and TFV Diphosphate and FTC Triphosphate in Dried Blood Spots in the iPrEx Open Label Extension: Implications for Pre-exposure Prophylaxis Adherence Monitoring

artículo científico publicado en 2015

Strong relationship between oral dose and tenofovir hair levels in a randomized trial: hair as a potential adherence measure for pre-exposure prophylaxis (PrEP)

artículo científico publicado en 2014

Study product adherence measurement in the iPrEx placebo-controlled trial: concordance with drug detection

artículo científico publicado en 2014

Supporting study product use and accuracy in self-report in the iPrEx study: next step counseling and neutral assessment

artículo científico publicado en 2012

Symptoms, Side Effects and Adherence in the iPrEx Open-Label Extension

artículo científico publicado en 2016

Syphilis predicts HIV incidence among men and transgender women who have sex with men in a preexposure prophylaxis trial

artículo científico publicado en 2014

T-cell activation and memory phenotypes in cerebrospinal fluid during HIV infection

artículo científico publicado en 2005

Target cell APOBEC3C can induce limited G-to-A mutation in HIV-1

artículo científico publicado en 2007

Tenofovir disoproxil fumarate for prevention of HIV infection in women: a phase 2, double-blind, randomized, placebo-controlled trial

artículo científico publicado en 2007

The Effect of Depressive Symptoms on Adherence to Daily Oral PrEP in Men who have Sex with Men and Transgender Women: A Marginal Structural Model Analysis of The iPrEx OLE Study

artículo científico publicado en 2016

The FACTS about women and pre-exposure prophylaxis

artículo científico publicado en 2015

The Safety of Tenofovir-Emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP) in Individuals With Active Hepatitis B.

artículo científico publicado en 2015

The clinical implications of reduced viral fitness

article

The future of PrEP among transgender women: the critical role of gender affirmation in research and clinical practices

artículo científico publicado en 2016

The potential impact of pre-exposure prophylaxis for HIV prevention among men who have sex with men and transwomen in Lima, Peru: a mathematical modelling study

artículo científico publicado en 2012

The role of viral fitness in HIV pathogenesis

artículo científico publicado en 2005

Time course of cerebrospinal fluid responses to antiretroviral therapy: evidence for variable compartmentalization of infection.

artículo científico publicado en 1999

Transactional sex and prevalence of STIs: a cross-sectional study of MSM and transwomen screened for an HIV prevention trial

artículo científico publicado en 2014

Transgender Women in Clinical Trials of Pre-Exposure Prophylaxis

artículo científico publicado en 2016

Transmitted drug resistance in persons with acute/early HIV-1 in San Francisco, 2002-2009

artículo científico publicado en 2010

Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study

artículo científico publicado en 2014

Use of antiretrovirals for HIV prevention: what do we know and what don't we know?

artículo científico publicado en 2013

Values and Preferences on the Use of Oral Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among Multiple Populations: A Systematic Review of the Literature

artículo científico publicado en 2017

Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia.

artículo científico publicado en 2001

Virological evaluation of the ‘Ottawa case’ indicates no evidence for HIV-1 superinfection

article

Weighing the risk of drug resistance with the benefits of HIV preexposure prophylaxis

artículo científico publicado en 2015

Whither or wither microbicides?

artículo científico publicado en 2008

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda